Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Total
Balance at Dec. 31, 2018 $ 0 $ 179,503,000 $ (45,000) $ (175,640,000) $ 0 $ 3,818,000
Balance (in shares) at Dec. 31, 2018 769,890       0  
Release of restricted common stock $ 0 (65,000) 0 0 $ 0 (65,000)
Release of restricted common stock (in shares) 6,193,000       0  
Issuance of warrants for common stock $ 0 0 0 0 $ 0 0
Issuance of warrants for common stock (in shares) 0       0  
Currency translation adjustment $ 0 0 (11,000) 0 $ 0 (11,000)
Net loss 0 0 0 (2,565,000) 0 (2,565,000)
Balance at Mar. 31, 2019 $ 0 179,438,000 (56,000) (178,205,000) $ 0 1,177,000
Balance (in shares) at Mar. 31, 2019 776,083       0  
Balance at Dec. 31, 2019 $ 0 188,320,000 (48,000) (187,678,000) $ 517,000 594,000 [1]
Balance (in shares) at Dec. 31, 2019 1,245,238       250,000  
Issuance of common stock and warrants, net of offering costs $ 0 725,000 0 0 $ 0 725,000
Issuance of common stock, net of issuance costs (in shares) 91,062          
Issuance of common stock in connection with notes payable $ 0 4,000 0 0 $ 0 4,000
Issuance of common stock in connection with notes payable (in shares) 500       0  
Issuance of warrants in connection with convertible notes payable $ 0 630,000 0 0 $ 0 630,000
Convertible preferred stock dividend 0 (20,000) 0 0 20,000 (20,000)
Stock-based compensation expense $ 0 75,000 0 0 $ 0 75,000
Stock compensation expense (in shares) 2,000       0  
Restricted awards cancelled $ 0 0 0 0 $ 0 0
Restricted awards cancelled (in shares) (550,000)       0  
Release of restricted common stock $ 0 0 0 0 $ 0 0
Release of restricted common stock (in shares) 353       0  
Issuance of warrants for common stock, in connection with convertible preferred stock offering (in shares)         0  
Net loss $ 0 0 0 (2,680,000) $ 0 (2,680,000)
Balance at Mar. 31, 2020 $ 0 $ 189,734,000 $ (48,000) $ (190,358,000) $ 537,000 $ (672,000)
Balance (in shares) at Mar. 31, 2020 1,338,603       250,000  
[1] The condensed consolidated balance sheet as of December 31, 2019 was derived from the audited consolidated balance sheet as of that date.